Skip to main content
  • Policy
    Get Involved
    Join BIOAction
    View Advocacy Toolkit
    Patient Advocacy
    Human Health
    Cost and Value of Biopharmaceuticals
    Antimicrobial Resistance
    Vaccines & Biodefense
    Drug Development & Review
    International
    Global Markets & Trade
    Multilateral Organizations
    Intellectual Property
    National Security
    Science & Regulatory
    All Policy
    Patient Advocacy

    Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.

  • Member
    Membership Options
    Become a BIO Member
    Member Directory
    Have a Voice
    Membership Eligibility
    Member Toolkit
    Benefits By Sector
    .
    Human Health
    Startups
    .
    Non-R&D Companies
    Member Savings
    VWR, Part of Avantor
    75% off Lab Supplies
    Save with BIO
    Save with BIO
  • News & Insights
    Latest biotech news
    Popular blogs
    Events
    Policy
    BIO Statements
    Press Releases
    Letters, Testimony & Comments
    Amicus Briefs
    BIO Reports
    Industry Analysis Reports
    Biotech Jobs
    Economic Development Best Practices
    BIO Briefly
    Issue Briefs
    BIO.News
    I am BIO Podcast
    All News & Insights

    Sign up for the BIO.News Newsletter >

  • Events
    Event Portfolio
    Business Development
    Health
    International
    Professional Development
    Members Only
    All Events
    BIO International Convention

    June 22-25, 2026 | San Diego, CA

    Learn More
    BIO Investor Forum
    BIO Asia-Taiwan

    July 15-19, 2026
    Taipei, Taiwan

    BIO Patient & Health Advocacy Summit
    BIO Patient Advocacy Changemakers Event

    October 22-23, 2026
    Washington, D.C

    BIO Asia-Taiwan
    BIO Europe

    November 9-11, 2026
    Cologne, Germany

    BIO Webinars

    Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.

  • About
    About Us
    Learn about our priorities
    BIO Leadership
    Meet BIO's Senior Leadership and Board of Directors
    Biotech Basics
    Read about biotechnology
    Industry Recognition
    Get to know the outstanding people and companies BIO supports
    Careers @ BIO
    Explore job openings with BIO today
  • Resource Hub
    Latest Resources
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Content Hub
    Biotech News (BIO.News)
    BIO.News Newsletter
    I am BIO Podcast
    BIO Advocacy Toolkit
    Resources Hub
    BIO Early-Stage Resources Hub
    BIO Professional Development
    BIO Webinars
    BIO Microsites
    Clinical Trials: The Power of Participation
    Covid Vaccine Facts
  • Search Results
    Previously Searched
Logo
Logo
Home
Search
  • Policy
    Human HealthPatient AdvocacyInternationalIntellectual PropertyNational SecurityScience & RegulatoryAll Policies
  • Member
    Become a BIO MemberBenefits By Sector
    Human HealthStartupsNon-R&D Companies
    Member DirectoryHave a VoiceMembership EligibilitySavings
  • News & Insights
    Press ReleasesBio.News BlogLetters, Testimony & CommentsAmicus BriefsIndustry Analysis ReportsBiotech JobsEconomic Development Best PracticesIssue BriefsBIO.NewsVideosAll News & Insights
  • Events
    BIO International ConventionBIO Asia-TaiwanAll Events
  • About
    About UsBIO LeadershipBiotech BasicsIndustry RecognitionCareers @ BIO
  • Resource Hub
    Biotech News (BIO.News)BIO.News NewsletterI am BIO PodcastBIO Advocacy ToolkitBIO Early-Stage Resources HubBIO Professional DevelopmentBIO WebinarsClinical Trials: The Power of ParticipationCovid Vaccine Facts
Search Results
Previously Searched
Search Results
Previously Searched
3232 results found
Expand All
Apply All
3232 results found

BIO, Biocom, and California Life Sciences Sue to Block CMS GLOBE Rule
Share
Press Release  •  November 7, 2026
Complaint argues HHS and CMS exceeded statutory authority; rule puts patient access, investment in future innovation, and America’s long-term biotechnology leadership at risk.WASHINGTON, DC & SAN DIEGO, CA & SAN FRANCISCO, CA - The Biotechnology Innovation Organization (BIO), Biocom, and California Life Sciences (CLS), today filed a complaint in the Northern District of California challenging a final rule from the Centers for Medicare & Medicaid Services (CMS): the Global Benchmark for Efficient Drug Pricing Model (GLOBE).The groups, which collectively represent more than one-third of America’s biotech companies, contend that CMS, in finalizing the GLOBE model, exceeded its statutory authority to test payment and service delivery models that address a defined population with deficits in care. GLOBE rewrites the Medicare statute to force American biotech innovators to rebate the difference between the price of certain Medicare Part B medicines in the US and government-controlled prices in 19 foreign countries, effectively importing foreign price controls. The groups also assert that GLOBE violates appropriations law and constitutional principles, including the separation of powers and non-delegation doctrines."Patients need policies that lower their prescription costs without jeopardizing access to new medicines today and in the future," said Joe Franklin, Chief Legal and Policy Officer, BIO. "By finalizing the GLOBE model, CMS crossed the limits Congress placed on its authority, and ultimately, put patients, innovators, and American competitiveness at risk. We cannot - and should not - import policies that leave Americans behind and threaten American leadership in global biotechnology."GLOBE fails to meaningfully address access and affordability challenges Americans face and will instead cause irreparable harm to the future of biomedical innovation and America’s most vulnerable patients waiting for cures. A January 2026 analysis found that just 0.3% of…
Read More

BIOTECanada
Share
BIO Business Solutions - Member Association
Through its partnership with the Biotechnology Innovation Organization (BIO), the international organization that represents the biotechnology industry, BIOTECanada offers its members the opportunity to take advantage of several of the BIO Business Solutions® programs, as listed below. BIO members located in Canada can also benefit from these cost-savings programs. Click on the company name to learn more about an individual program.There is no fee for BIOTECanada members or BIO members located in Canada to utilize any of the programs and BIO membership is not a requirement for BIOTECanada members.
Read More

Lab Equipment Service Contract Consolidation
Share
BIO Business Solutions - Program
About SU GroupSpecialty Underwriters (SU Group) delivers a customized equipment maintenance solution that streamlines contract management while reducing costs. By consolidating service contracts into one agreement, SU Group provides budget predictability, convenience, and flexibility — ensuring equipment stays covered without the administrative burden of managing multiple vendors.For life sciences companies, SU Group’s coverage spans a wide range of categories, including:General laboratory equipmentMolecular biologyProtein analysisGenomics & proteomicsClinical & R&D lab equipmentCell biology instrumentsImaging & microscopyBiochemical analysisThrough BIO Business Solutions®, member companies receive exclusive discounts and consolidated service solutions, helping them control costs while keeping critical equipment operational.
Read More

Executive Consulting & C-Suite Placement
Share
BIO Business Solutions - Program
About BiotechExecBiotechExec is a national executive consulting and placement network dedicated to the life sciences. With more than 400 senior leaders across its IGNITE Network — including CEOs, CFOs, COOs, CSOs, CMOs, and board directors — BiotechExec provides companies with access to proven executives who bring both expertise and extensive industry connections.For startups through growth-stage biotechs, BiotechExec offers flexible engagement models ranging from fractional or interim placements to full-time hires, ensuring companies have the leadership they need to reach their next milestone.Through BIO Business Solutions®, member companies receive exclusive discounts and a complimentary executive advisory session, making BiotechExec a trusted partner for strategic leadership and organizational growth.Corporate Overview (PDF) 
Read More

BIO frequently provides webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services. Recordings of prior BIO
Share
BIO frequently provides webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services. Recordings of prior BIO webinars are searchable below.
Read More

Protecting America Before the Next Health Emergency
Share
Human Health, Biodefense and Vaccines  •  Toolkit  •  November 4, 2026
For 20 years, the Pandemic and All-Hazards Preparedness Act (PAHPA) has protected Americans from disease outbreaks, bioterrorism, and natural disasters.The landmark law, which marks its 20th anniversary in December 2026, authorizes critical Department of Health and Human Services programs to prepare for and respond to public health emergencies. But keyauthorizations expired in 2023, leaving Congress with unfinished business.
Read More

BIO Board of Directors
Share
.oc-accordionGroup__rgnItems .oc-accordionGroup__item:first-child:not(:only-child) { display: none; }
Read More

PDABs Promised Cost Savings - Patients are Still Waiting
Share
Human Health, Government Price Setting  •  Toolkit  •  November 2, 2026
In recent years, nine states have set up Prescription Drug Affordability Boards (PDABs) in an effort to make medicines more affordable. These boards review certain high-cost drugs and some of them can impose “Upper Payment Limits” that cap what insurers can pay for the treatments. But despite lawmakers’ good intentions, these boards have failed to help patients.
Read More

BioMed SA
Share
BIO Business Solutions - Member Association
Through its partnership with BIO and the Texas Healthcare and Bioscience Institute (THBI), BioMed SA offers its members the opportunity to take advantage of the BIO Business Solutions® programs listed below. Click on the company name to learn more.There is no fee for BioMed SA members to participate.
Read More

Partner Smarter at JPM Week 2027 with BIO Partnering
Share
Webinars  •  October 29, 2026
BIO Partnering™ returns to the San Francisco Marriott Marquis for JPM Week 2027 with enhanced tools to help you identify the right partners, schedule meetings efficiently, and make the most of one of the biotech industry's busiest weeks.Join this webinar for a guided walkthrough of the BIO Partnering platform, including the latest features designed to simplify partner discovery, streamline meeting scheduling, and help you manage a full week of partnering. You'll also learn how to navigate BIO's onsite meeting space, schedule meetings across multiple locations and stay informed about networking events and activities happening throughout JPM Week.Whether you're attending for the first time or are a seasoned partnering professional, this session will provide practical tips to set you up for success before you arrive in San Francisco.In this webinar, we cover:- Overview of BIO Partnering @JPM Week 2027- Tour of BIO's onsite meeting space at the San Francisco Marriott Marquis- Best practices for finding partners and scheduling productive meetings- Live demonstration of the BIO Partnering system- Tips for managing meetings across multiple JPM Week locations- Intro to bioRSVP networking events mobile app Learn more about BIO Partnering @JPM Week: https://bpjw.bio.org/ 
Read More
JPM 2020 image

Pagination

  • First First page
  • Prev Previous page
  • …
  • 2
  • 3
  • 4
  • …
  • Next Next page
  • Last Last page
Biotechnology Innovation Organization
Explore BIO
Policy
Events
About
Industry Insights
Join Now
BIO PAC
For Members
Member Directory
BIO Policy Committees
Cost-Savings Program
BIO Events
BIO Investment and Growth Summit
BIO Partnering™ for Oncology
BIO International Convention
BIO Partnering™ at JPM Week
BIO Patient Advocacy Changemakers Events
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2026 All Rights Reserved
Privacy Policy
Terms of Use
Contact BIO